Home › Anaplastic Large-Cell Lymphoma › Missouri › St. Louis
Anaplastic Large-Cell Lymphoma clinical trials in St. Louis, MO
4 studies for Anaplastic Large-Cell Lymphoma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecruitingPhase 1/2
- Washington University School of Medicine in St. Louis, St Louis
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Washington University in St. Louis, St Louis
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
RecruitingPhase 3
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- and 1 more
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Washington University (Data Collection Only), St Louis
Anaplastic Large-Cell Lymphoma trials in other cities
- Durham, NC4 studies
- Rochester, MN4 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- New York City, NY3 studies
- Columbus, OH3 studies
- Baldwin Park, CA3 studies
- Philadelphia, PA3 studies
- Boston, MA3 studies
- Seattle, WA3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.